Zobrazeno 1 - 10
of 29
pro vyhledávání: '"David Y.C. Huang"'
Publikováno v:
Medical Dosimetry. 37:334-338
The purpose of this work was to determine the relative sensitivity of skin QED diodes, optically stimulated luminescent dosimeters (OSLDs) (microStar™ DOT, Landauer), and LiF thermoluminescent dosimeters (TLDs) as a function of distance from a phot
Autor:
Tien Chi Yeh, David Y.C. Huang, Shih Ming Hsu, Ji Hong Hong, Shung-Shung Sun, Annie Y.H. Tipton, Wei Li Chen, Chien Yi Yeh
Publikováno v:
Medical Physics. 35:5558-5564
High dose rate brachytherapy (HDR-BT) is one of the many modalities for prostate cancer treatment. Due to the nature of HDR-BT, in vivo dosimetry is feasible and can be used to verify consistent dose delivery. In order to validate a dose verification
Publikováno v:
Radiation Measurements. 43:538-541
The thermoluminescent dosimeters (TLDs) are widely used for measuring the radiation dose. However, the luminescence centers of TLD disappeared by reading process, and then repetition of measurement is impossible. Radiophotoluminescent glass dosimeter
Autor:
Shih Ming Hsu, Tien Chi Yeh, Chin Hui Wu, David Y.C. Huang, Hsi Wen Yang, Chin Chang Lu, Wei Li Chen, Wei Lin Hsu
Publikováno v:
Radiation Measurements. 42:621-624
The radiophotoluminescent glass dosimeter (RPLGD) was developed in the late 1950s while the reading technology was not sensitive enough to measure the low radiation dose and glass element sensitivity to radiation was also quite low. In recent years,
Publikováno v:
Urology. 62:1073-1077
To evaluate the disease and treatment-related factors for predicting biochemical freedom from recurrence (BFR) in patients with clinically localized prostate cancer undergoing permanent prostate brachytherapy.Between November 1992 and June 1998, 883
Autor:
Steven A. Leibel, David Y.C. Huang, Rosemary Purrazzella, Michael W. Kattan, Paul A. Fearn, Louis Potters, Sheryl Brustein
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 56:749-754
To assess the difference in biochemical freedom from relapse (BFR) between patients with clinically localized prostate cancer having Gleason Grade (GG) 3 + 4 vs. 4 + 3 disease treated with permanent prostate brachytherapy (PPB).One thousand twenty-ni
Publikováno v:
Brachytherapy. 2:26-31
Purpose: To assess the difference in prostate-specific antigen (PSA) response kinetics in patients undergoing either 125I or 103Pd permanent prostate brachytherapy (PPB). Methods and Materials: Between 1997 and 1999, 333 patients underwent PPB as mon
Publikováno v:
Biomedical Engineering: Applications, Basis and Communications. 14:35-39
To estimate the respiration-induced dosimetric change at beam edge during a beam-on interval of radiotherapy, by the integration of a mathematical model for organ motion and a modeled beam profile. A method is proposed which incorporated the effects
Autor:
Jeng Hung Lee, Chun Yen Yu, Ya-Ju Hsieh, Yi Jen Liao, Chin Hui Wu, Shih Ming Hsu, David Y.C. Huang, Li Cheng Kuo, Ji An Liang
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 9, p e44528 (2012)
PLoS ONE, Vol 7, Iss 9, p e44528 (2012)
Dose distributions of (192)Ir HDR brachytherapy in phantoms simulating water, bone, lung tissue, water-lung and bone-lung interfaces using the Monte Carlo codes EGS4, FLUKA and MCNP4C are reported. Experiments were designed to gather point dose measu
Autor:
David Y.C. Huang, Shih-Ming Hsu
Publikováno v:
Advances in Cancer Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67739c0b5cc362f2a5fadd4b8c7928c3
http://www.intechopen.com/articles/show/title/radio-photoluminescence-glass-dosimeter-rplgd-
http://www.intechopen.com/articles/show/title/radio-photoluminescence-glass-dosimeter-rplgd-